Relationship of obesity and insulin resistance with the cerebrovascular reactivity: A case control study

Cardiovascular Diabetology

Volumn 13, Issue 1, 2014, Pages

  Rodríguez Flores, Marcela ^a   García García, Eduardo ^a   Cano Nigenda, Claudia V ^b   Cantú Brito, Carlos ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b LIVER RESEARCH UNIT   (Mexico)

Author keywords

Abdominal obesity; Cerebrovascular; Insulin resistance; Obesity; Transcranial doppler

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; ARTICLE; BLOOD FLOW VELOCITY; BLOOD VESSEL REACTIVITY; BODY HEIGHT; BODY MASS; BODY WEIGHT; BRAIN ARTERY; BREATH HOLDING INDEX; CASE CONTROL STUDY; CEREBROVASCULAR REACTIVITY; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; EPWORTH SLEEPINESS SCALE; FEMALE; GLUCOSE BRAIN LEVEL; GLUCOSE INTOLERANCE; HEMODYNAMICS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MATSUDA INDEX; MEAN FLOW VELOCITY; METABOLIC SYNDROME X; NECK CIRCUMFERENCE; OBESITY; OBSERVATIONAL STUDY; PREVALENCE; PULSATILITY INDEX; QUESTIONNAIRE; RATING SCALE; RESISTANCE INDEX; SLEEP APNEA CLINICAL SCALE; SLEEP DISORDERED BREATHING; SOMNOLENCE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; BLOOD FLOW VELOCITY; BODY MASS INDEX; CASE-CONTROL STUDIES; CEREBROVASCULAR DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; OBESITY; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; VASOMOTOR SYSTEM; WAIST CIRCUMFERENCE;

EID: 84891686296     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-13-2     Document Type: Article

References (42)

1. Freedman DS, Khan LK, Serdula MK, Galuska DA, Dietz WH. Trends and correlates of class 3 obesity in the United States from 1990 through 2000. JAMA 2002, 288:1758-1761. 10.1001/jama.288.14.1758, 12365960.
2. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006, 444:840-846. 10.1038/nature05482, 17167471.
3. Ronti T, Lupattelli G, Mannarino E. The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf) 2006, 64:355-365.
4. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006, 367:1747-57. 10.1016/S0140-6736(06)68770-9, 16731270.
5. Norrving B, Kissela B. The global burden of stroke and need for a continuum of care. Neurology 2013, 80:S5-12. 10.1212/WNL.0b013e3182762397, 23319486.
6. Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, et al. American heart association; American stroke association stroke council: primary prevention of ischemic stroke: a guideline from the American heart association/American stroke association stroke council: cosponsored by the atherosclerotic peripheral vascular disease interdisciplinary working group; cardiovascular nursing council; clinical cardiology council; nutrition, physical activity, and metabolism council; and the quality of care and outcomes research interdisciplinary working group; American academy of neurology. Stroke 2006, 37:1583-1633. 10.1161/01.STR.0000223048.70103.F1, 16675728.
7. Valencia-Flores M, Rebollar V, Santiago V, Orea A, Rodríguez C, Resendiz M, et al. Prevalence of pulmonary hypertension and its association with respiratory disturbances in obese patients living at moderately high altitude. Int J Obes 2004, 28:1174-1180.
8. Young T, Peppard P, Gottlieb D. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002, 165:1217-1239. 10.1164/rccm.2109080, 11991871.
9. Arzt M, Young T, Finn L, Skatrud JB, Bradley TD. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 2005, 172:1447-1451. 10.1164/rccm.200505-702OC, 2718439, 16141444.
10. Hung J, Whitford EG, Parsons RW, Hillman DR. Association of sleep apnoea with myocardial infarction in men. Lancet 1990, 336:261-264. 10.1016/0140-6736(90)91799-G, 1973968.
11. Calvin AD, Albuquerque FN, Lopez-Jimenez F, Somers VK. Obstructive sleep apnea, inflammation, and the metabolic syndrome. Metab Synd Relat Disord 2009, 7:271-278.
12. Mulgrew AT, Fox N, Ayas NT, Ryan F. Diagnosis and initial management of obstructive sleep apnea without polysomnography. Ann Intern Med 2007, 146:157-166. 10.7326/0003-4819-146-3-200702060-00004, 17283346.
13. Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 2008, 168:1617-1624. 10.1001/archinte.168.15.1617, 18695075.
14. The Emerging Risk Factors Collaboration Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet 2011, 377:1085-95. 3145074, 21397319, The Emerging Risk Factors Collaboration.
15. Singh AS, Atam V, Patel ML, Chaudhary SC, Sawlani KK, Das L. Carotid intima media thickness as a reflection of generalized atherosclerosis is related to body mass index in ischemic stroke patients. N Am J Med Sci 2013, 5(3):228-2234. 3632029, 23626961.
16. Markus HS. Transcranial doppler ultrasound. Br Med Bull 2000, 56:378-88. 10.1258/0007142001903021, 11092087.
17. Bae HJ, Lee J, Park JM, Kwon O, Koo JS, Kim BK, et al. Risk factors of intracranial cerebral atherosclerosis among asymptomatics. Cerebrovasc Dis 2007, 24:355-60. 10.1159/000106982, 17690548.
18. Settakis G, Lengyel A, Molnar C, Bereczki D, Csiba L, Fulesdi B. Transcranial doppler study of cerebral hemodynamics changes during breath-holding and hyperventilation test. J Neuroimaging 2002, 12:252-258.
19. Markus HS, Harrison M. Estimation of cerebrovascular reactivity using transcranial doppler, including the use of breath holding as the vasodilatory stimulus. Stroke 1992, 23:669-673.
20. Gur AY, Bornstein NM. TCD and de diamox test for testing vasomotor reactivity: clinical significance. Neurol Neurochir Pol 2001, 35:51-6.
21. Vernieri F, Pasqualetti P, Passarelli F, Rossini PM, Silvestrini M. Outcome of carotid artery occlusion is predicted by cerebrovascular reactivity. Stroke 1999, 30:593-8. 10.1161/01.STR.30.3.593, 10066857.
22. Silvestrini M, Vernieri F, Pasqualetti P, Matteis M, Passarelli F, Troisi E, et al. Impaired cerebral vasoreactivity and risk of stroke in patients with asymptomatic carotid artery stenosis. JAMA 2000, 283:2122-7. 10.1001/jama.283.16.2122, 10791504.
23. Sigimori H, Ibayashi S, Fujii K, Sadoshima S, Kuwabara Y, Fujishima M. Can transcranial doppler really detect reduced cerebral perfusion states?. Stroke 1995, 26:2053-2060. 10.1161/01.STR.26.11.2053, 7482649.
24. Giannopoulos S, Boden-Albala B, Choi JH, Carrera E, Doyle M, Perez T, et al. Metabolic syndrome and cerebral vasomotor reactivity. Eur J Neurol 2010, 17:1457-1462. 10.1111/j.1468-1331.2010.03087.x, 20500212.
25. Uchino K, Lin R, Zaidi SF, Kuwabara H, Sashin D, Bircher N, et al. Increased cerebral oxygen metabolism and ischemic stress in subjects with metabolic syndrome-associated risk factors: preliminary observations. Transl Stroke Res 2010, 1(3):178-183. 10.1007/s12975-010-0028-2, 3201728, 22034586.
26. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2008, 31:S55-S60. American Diabetes Association.
27. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from casting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419. 10.1007/BF00280883, 3899825.
28. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing. Diabetes Care 1999, 22:1462-147. 10.2337/diacare.22.9.1462, 10480510.
29. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome: a new worldwide definition. Lancet 2005, 366:1059-1062. 10.1016/S0140-6736(05)67402-8, 16182882.
30. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; americanheart association; world heart federation; International atherosclerosismsociety; and International association for the study of obesity. Circulation 2009, 120:1640-1645. 10.1161/CIRCULATIONAHA.109.192644, 19805654.
31. Preis SR, Massaro JM, Hoffman U, D'Agostino RBS, Levy D, Robins SJ, et al. Neck circumference as a novel measure of cardiometabolic risk: the Framingham heart study. J Clin Endocrinol Metab 2010, 95:3701-3710. 10.1210/jc.2009-1779, 2913042, 20484490.
32. Schwab RJ, Pasirstein M, Pierson R, Mackley A, Hachadoorian R, Arens R, et al. Identification of upper airway anatomic risk factors for obstructive sleep apnea with volumetric magnetic resonance imaging. Am J Respir Crit Care Med 2003, 168:522-530. 10.1164/rccm.200208-866OC, 12746251.
33. Williams AJ, Yu G, Santiago S, Stein M. Screening for sleep apnea using pulse oximetry and a clinical score. Chest 1991, 100:631-635. 10.1378/chest.100.3.631, 1889245.
34. Drager LF, Polotsky VY, Lorenzi-Filho G. Obstructive sleep apnea: an emerging risk factor for atherosclerosis. Chest 2011, 140:534-42. 10.1378/chest.10-2223, 3198492, 21813534.
35. Sood A. Altered resting and exercise respiratory physiology in obesity. Clin Chest Med 2009, 30:445-54. 10.1016/j.ccm.2009.05.003, 2765111, 19700043.
36. Papa G, Degano C, Iurato MP, Licciardello C, Maiorana R, Finocchiaro C. Macrovascular complication phenotypes in type 2 diabetic patients. Cardiovasc Diabetol 2013, 12:20. 10.1186/1475-2840-12-20, 3558439, 23331854.
37. Brundel M, van den Verg E, Reijmer YD, de Bresser J, Kappelle DJ, Biessels GJ. Cerebral haemodynamics, cognition and brain volumes in patients with type 2 diabetes. J Diabetes Complications 2012, 26:205-209. 10.1016/j.jdiacomp.2012.03.021, 22520398.
38. Yates KF, Sweat V, Yau PL, Turchiano MM, Convit A. Impact of metabolic syndrome on cognition and brain: a selected review of the literature. Arterioscler Thromb Vasc Biol 2012, 32:2060-2067. 10.1161/ATVBAHA.112.252759, 3442257, 22895667.
39. Gunstad J, Spitznagel MB, Paul RH, Cohen RA, Kohn M, Luyster FS, Clark R, Williams LM, Gordon E. Body mass index and neuro-psychological function in healthy children and adolescents. Appetite 2008, 50:246-251. 10.1016/j.appet.2007.07.008, 17761359.
40. Novo S, Peritore A, Trovato RL, Guarneri FP, Lisi DD, Muratori I, et al. Preclinical atherosclerosis and metabolic syndrome increase cardio- and cerebrovascular events rate: a 20-year follow-up. Cardiovasc Diabetol 2013, 12:155. 10.1186/1475-2840-12-155, 24152423.
41. Wijnhoud AD, Koudstaal PJ, Dippel DW. The prognostic value of pulsatility index, flow velocity, and their ratio, measured with TCD ultrasound, in patients with a recent TIA or ischemic stroke. Acta Neurol Scand 2011, 124:238-44. 10.1111/j.1600-0404.2010.01462.x, 21198447.
42. Cupini LM, Diomedi M, Placidi F, Silvestrini M, Giacomini P. Cerebrovascular reactivity and subcortical infarctions. Arch Neurol 2001, 58:577-81.